1.
Mantovani LG, Furneri G, Bitonti R, et al. Cost-Effectiveness Analysis of Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis: An Italian Societal Perspective. Farmeconomia. Health Economics and Therapeutic Pathways. 2019;20(1). https://doi.org/10.7175/fe.v20i1.1437